Merck & Dohme (MSD) South Africa (SA) has raised alarm over the country’s high cervical cancer burden, with around 12 000 cases diagnosed annually and more than 60% resulting in death.

MSD emphasises that HPV vaccination remains the most effective preventive measure and is calling for expanded access for older women, particularly those living with HIV.

Zwelethu Bashman, director at MSD SA, stressed that education and awareness are crucial to strengthen prevention efforts. “Cervical cancer is preventable and treatable if detected early,” he said.

Currently, school-based HPV vaccination programmes target girls aged 9 to 14, but MSD is urging the National Department of Health to implement strategies allowing women beyond this age group to also receive the vaccine.

–ChannelAfrica–